Erdenechimeg Dashzevge
Research Subjects
Erdenechimeg Dashzevge has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Badgar Battsetseg
Institute of Veterinary Medicine , Zaisan , Khan-uul district , Ulaanbaatar , Mongolia
3 shared publicationsAyushjav Narantuya
2 shared publicationsBayan Dulamsuren
2 shared publications- Bazartseren Boldbaatar
School of Veterinary Medicine, Mongolian University of Life Sciences, Ulaanbaatar, Mongolia
2 shared publications Bumduuren Tuvshintulga
2 shared publicationsByamba Boldbaatar
2 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Walter de Gruyter GmbH in Journal of Veterinary Research
Serological surveillance of equine herpesvirus types 1 and 4 in Mongolia
Introduction: Equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) are major viral pathogens of horses causing respiratory disease, abortion and neurological disorders, leading to significant economic losses worldwide. In Mongolia, horses are raised under nomadic and extensive grazing systems, which may facilitate disease transmission. Nationwide data are scarce on the prevalence of infection with these viruses, and to generate these data for a broad expanse of Mongolia, surveillance was carried out. Material and Methods: Large-scale serological testing was conducted using peptide-based ELISAs. A total of 1,222 serum samples were collected from horses across 12 provinces of Mongolia. Results: Antibodies against EHV-1 were detected in 6.7% of samples, antibodies against EHV-4 in 20.7%, and antibodies against both in 2.8%. Overall, 301 horses (24.6%) were positive for at least one virus. The seroprevalence of EHV-4 was significantly higher than that of EHV-1 (P-value < 0.0001). Conclusion: These findings provide baseline epidemiological data for Mongolia and support the development of risk-based surveillance and control strategies to reduce the impact of equine herpesvirus infections.
- 12 November 2026
- Published by Walter de Gruyter GmbH in Journal of Veterinary Research
Open AccessSerological surveillance of equine herpesvirus types 1 and 4 in Mongolia
Introduction: Equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4) are major viral pathogens of horses causing respiratory disease, abortion and neurological disorders, leading to significant economic losses worldwide. In Mongolia, horses are raised under nomadic and extensive grazing systems, which may facilitate disease transmission. Nationwide data are scarce on the prevalence of infection with these viruses, and to generate these data for a broad expanse of Mongolia, surveillance was carried out. Material and Methods: Large-scale serological testing was conducted using peptide-based ELISAs. A total of 1,222 serum samples were collected from horses across 12 provinces of Mongolia. Results: Antibodies against EHV-1 were detected in 6.7% of samples, antibodies against EHV-4 in 20.7%, and antibodies against both in 2.8%. Overall, 301 horses (24.6%) were positive for at least one virus. The seroprevalence of EHV-4 was significantly higher than that of EHV-1 (P-value < 0.0001). Conclusion: These findings provide baseline epidemiological data for Mongolia and support the development of risk-based surveillance and control strategies to reduce the impact of equine herpesvirus infections.
- 23 July 2026
- Published by Springer Nature in Archives of Virology
- Vol. 171 (8)
Effective inactivated lumpy skin disease vaccine for cattle using a field viral strain and Montanide 206
- 23 July 2026
- Published by Springer Nature in Archives of Virology
- Vol. 171 (8)
Effective inactivated lumpy skin disease vaccine for cattle using a field viral strain and Montanide 206
- Open Access
- 5 June 2025
- Published by Springer Nature in Research Square
Effective inactivated lumpy skin disease vaccine for cattle using a field viral strain and Montanide 206
Lumpy skin disease (LSD) causes significant economic losses to cattle industries. In Mongolia, LSD outbreaks were first reported in 2021, with a few additional cases later that year. The situation has since alleviated due to effective control measures, including the use of live-attenuated vaccines. However, unlike the inactivated vaccine, live-attenuated vaccines carry risks, including genetic recombination and vaccine-associated clinical symptoms and outbreaks. Our research group previously isolated a field strain of LSDV, designated DO-21, from the first outbreak in Mongolia in 2021. Using this laboratory-adapted strain, we developed an inactivated vaccine by treating it with binary ethyleneimine and formulating it with Montanide ISA 206, a water-in-oil-water adjuvant. Safety was confirmed in mice and cattle using administrations of 3- and 7-fold higher doses of the inactivated vaccine, respectively. In the challenge experiments, all rabbits and cattle were fully protected by day 14 post-booster vaccination following a severe homologous challenge with same field strain (DO-21) without any clinical signs. On the same day, all five vaccinated rabbits showed seroconversion, while all five immunised calves exhibited seroconversion and neutralising antibodies, with interferon-gamma release detected in their blood samples following viral exposure. In addition, seroconversion persisted in all three vaccinated rabbits for at least 120 days post-prime vaccination, while both seroconversion and neutralising antibodies were maintained in all nine cattle for 120 days post-prime vaccination. In conclusion, inactivated vaccines are alternatives to live-attenuated vaccines, particularly in countries with sporadic cases of LSD or in non-endemic countries bordering endemic regions.
- 5 June 2025
- Published by Springer Nature in Research Square
Open AccessEffective inactivated lumpy skin disease vaccine for cattle using a field viral strain and Montanide 206
Lumpy skin disease (LSD) causes significant economic losses to cattle industries. In Mongolia, LSD outbreaks were first reported in 2021, with a few additional cases later that year. The situation has since alleviated due to effective control measures, including the use of live-attenuated vaccines. However, unlike the inactivated vaccine, live-attenuated vaccines carry risks, including genetic recombination and vaccine-associated clinical symptoms and outbreaks. Our research group previously isolated a field strain of LSDV, designated DO-21, from the first outbreak in Mongolia in 2021. Using this laboratory-adapted strain, we developed an inactivated vaccine by treating it with binary ethyleneimine and formulating it with Montanide ISA 206, a water-in-oil-water adjuvant. Safety was confirmed in mice and cattle using administrations of 3- and 7-fold higher doses of the inactivated vaccine, respectively. In the challenge experiments, all rabbits and cattle were fully protected by day 14 post-booster vaccination following a severe homologous challenge with same field strain (DO-21) without any clinical signs. On the same day, all five vaccinated rabbits showed seroconversion, while all five immunised calves exhibited seroconversion and neutralising antibodies, with interferon-gamma release detected in their blood samples following viral exposure. In addition, seroconversion persisted in all three vaccinated rabbits for at least 120 days post-prime vaccination, while both seroconversion and neutralising antibodies were maintained in all nine cattle for 120 days post-prime vaccination. In conclusion, inactivated vaccines are alternatives to live-attenuated vaccines, particularly in countries with sporadic cases of LSD or in non-endemic countries bordering endemic regions.
- Open Access
- 25 July 2024
- Published by Veterinary World in International Journal of One Health
Prevalence and risk factors of Hepatitis E virus infection among Bactrian camel herders in Bayankhongor province, Mongolia
Background and Aim:Hepatitis E virus (HEV) poses a global public health concern. HEV has a single serotype and 8 genotypes. There is inadequate knowledge about risk factors and zoonotic transmission pathways of hepatitis E virus in Mongolia, although the prevalence of HEV is, on average, 12% among the Mongolian population. This study aimed to estimate the prevalence and risk factors of HEV G8 infection in Bayankhongor province, Mongolia. Materials and Methods: Human serum samples (309) were collected in Bogd, Bayangovi, and Bayanlig districts of Bayankhongor province, Mongolia, with a control group consisting of non-camel herders. An in-house indirect enzyme-linked immunosorbent assay kit was used to detect anti-HEV IgG. The interviewer-administered questionnaire was used to gather the data. The assessment factors included age, sex, and occupation for the respondents. Univariate analyses were conducted using the Statistical Package for the Social Sciences version 26. The same population was tested for hepatitis B and C viruses (HBVs and HCVs) using rapid tests. Results: Of 309 samples, 41 (13.3%) tested positive for anti-HEV immunoglobulin G antibodies, 23 (7.4%) for HBV and 11 (3.6%) for HCV. HEV seropositivity was linked with water supply, khoormog consumption, and co-infection with HBV and HCV. Conclusion: HEV prevalence among Bayankhongor residents underscores potential transmission routes related to water supply and khoormog consumption, emphasizing the need for sequencing from human positive sera of HEV and preventive measures. We did not conduct the genotyping of positive human samples. Keywords: Bactrian camel herder, genotype 8, hepatitis E virus, indirect enzyme-linked immunosorbent assay, seroprevalence.
- 25 July 2024
- Published by Veterinary World in International Journal of One Health
Open AccessPrevalence and risk factors of Hepatitis E virus infection among Bactrian camel herders in Bayankhongor province, Mongolia
Background and Aim:Hepatitis E virus (HEV) poses a global public health concern. HEV has a single serotype and 8 genotypes. There is inadequate knowledge about risk factors and zoonotic transmission pathways of hepatitis E virus in Mongolia, although the prevalence of HEV is, on average, 12% among the Mongolian population. This study aimed to estimate the prevalence and risk factors of HEV G8 infection in Bayankhongor province, Mongolia. Materials and Methods: Human serum samples (309) were collected in Bogd, Bayangovi, and Bayanlig districts of Bayankhongor province, Mongolia, with a control group consisting of non-camel herders. An in-house indirect enzyme-linked immunosorbent assay kit was used to detect anti-HEV IgG. The interviewer-administered questionnaire was used to gather the data. The assessment factors included age, sex, and occupation for the respondents. Univariate analyses were conducted using the Statistical Package for the Social Sciences version 26. The same population was tested for hepatitis B and C viruses (HBVs and HCVs) using rapid tests. Results: Of 309 samples, 41 (13.3%) tested positive for anti-HEV immunoglobulin G antibodies, 23 (7.4%) for HBV and 11 (3.6%) for HCV. HEV seropositivity was linked with water supply, khoormog consumption, and co-infection with HBV and HCV. Conclusion: HEV prevalence among Bayankhongor residents underscores potential transmission routes related to water supply and khoormog consumption, emphasizing the need for sequencing from human positive sera of HEV and preventive measures. We did not conduct the genotyping of positive human samples. Keywords: Bactrian camel herder, genotype 8, hepatitis E virus, indirect enzyme-linked immunosorbent assay, seroprevalence.
- Open Access
- 1 July 2015
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 6 (5) , 623-629
Isolation and characterization of tick-borne encephalitis virus from Ixodes persulcatus in Mongolia in 2012
- 1 July 2015
- Published by Elsevier in Ticks and Tick-borne Diseases
- Vol. 6 (5) , 623-629
Open AccessIsolation and characterization of tick-borne encephalitis virus from Ixodes persulcatus in Mongolia in 2012